These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33568538)

  • 21. KL∗VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE∗4 carriers.
    Belloy ME; Eger SJ; Le Guen Y; Napolioni V; Deters KD; Yang HS; Scelsi MA; Porter T; James SN; Wong A; Schott JM; Sperling RA; Laws SM; Mormino EC; He Z; Han SS; Altmann A; Greicius MD; ; ; ;
    Neurobiol Aging; 2021 May; 101():123-129. PubMed ID: 33610961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of Plasma Neurofilament Light in the 1Florida Alzheimer's Disease Research Center (ADRC).
    Barker W; Quinonez C; Greig MT; Behar R; Chirinos C; Rodriguez RA; Rosselli M; Rodriguez MJ; Cid RC; Rundek T; McFarland K; Hanson K; Smith G; DeKosky S; Vaillancourt D; Adjouadi M; Marsiske M; Ertekin-Taner N; Golde T; Loewenstein DA; Duara R
    J Alzheimers Dis; 2021; 79(1):59-70. PubMed ID: 33216030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study.
    Bassett MT; Chen JT; Krieger N
    PLoS Med; 2020 Oct; 17(10):e1003402. PubMed ID: 33079941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points.
    Toledo JB; Habes M; Sotiras A; Bjerke M; Fan Y; Weiner MW; Shaw LM; Davatzikos C; Trojanowski JQ;
    J Alzheimers Dis; 2019; 69(3):783-793. PubMed ID: 31127775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LRP-1 polymorphism is associated with global and regional amyloid load in Alzheimer's Disease in humans in-vivo.
    Grimmer T; Goldhardt O; Guo LH; Yousefi BH; Förster S; Drzezga A; Sorg C; Alexopoulos P; Förstl H; Kurz A; Perneczky R
    Neuroimage Clin; 2014; 4():411-6. PubMed ID: 24596678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment.
    Insel PS; Hansson O; Mattsson-Carlgren N
    JAMA Neurol; 2021 Feb; 78(2):229-235. PubMed ID: 33044487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex modulates the ApoE ε4 effect on brain tau deposition measured by
    Liu M; Paranjpe MD; Zhou X; Duy PQ; Goyal MS; Benzinger TLS; Lu J; Wang R; Zhou Y
    Theranostics; 2019; 9(17):4959-4970. PubMed ID: 31410194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.
    Ossenkoppele R; Jansen WJ; Rabinovici GD; Knol DL; van der Flier WM; van Berckel BN; Scheltens P; Visser PJ; ; Verfaillie SC; Zwan MD; Adriaanse SM; Lammertsma AA; Barkhof F; Jagust WJ; Miller BL; Rosen HJ; Landau SM; Villemagne VL; Rowe CC; Lee DY; Na DL; Seo SW; Sarazin M; Roe CM; Sabri O; Barthel H; Koglin N; Hodges J; Leyton CE; Vandenberghe R; van Laere K; Drzezga A; Forster S; Grimmer T; Sánchez-Juan P; Carril JM; Mok V; Camus V; Klunk WE; Cohen AD; Meyer PT; Hellwig S; Newberg A; Frederiksen KS; Fleisher AS; Mintun MA; Wolk DA; Nordberg A; Rinne JO; Chételat G; Lleo A; Blesa R; Fortea J; Madsen K; Rodrigue KM; Brooks DJ
    JAMA; 2015 May; 313(19):1939-49. PubMed ID: 25988463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of a polygenic risk score for dementia in black and white individuals.
    Marden JR; Walter S; Tchetgen Tchetgen EJ; Kawachi I; Glymour MM
    Brain Behav; 2014 Sep; 4(5):687-97. PubMed ID: 25328845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
    Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Race/ethnic differences in AD survival in US Alzheimer's Disease Centers.
    Mehta KM; Yaffe K; Pérez-Stable EJ; Stewart A; Barnes D; Kurland BF; Miller BL
    Neurology; 2008 Apr; 70(14):1163-70. PubMed ID: 18003939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APOE and APOC1 promoter polymorphisms and the risk of Alzheimer disease in African American and Caribbean Hispanic individuals.
    Tycko B; Lee JH; Ciappa A; Saxena A; Li CM; Feng L; Arriaga A; Stern Y; Lantigua R; Shachter N; Mayeux R
    Arch Neurol; 2004 Sep; 61(9):1434-9. PubMed ID: 15364690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multifunctional Roles of APOE in Alzheimer's Disease Pathogenesis].
    Tokutake T; Kasuga K; Hara N; Ikeuchi T
    Brain Nerve; 2016 Jul; 68(7):703-12. PubMed ID: 27395454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perspectives From Black and White Participants and Care Partners on Return of Amyloid and Tau PET Imaging and Other Research Results.
    Rahman-Filipiak A; Lesniak M; Sadaghiyani S; Roberts S; Lichtenberg P; Hampstead BM
    Alzheimer Dis Assoc Disord; 2023 Oct-Dec 01; 37(4):274-281. PubMed ID: 37890053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using an Alzheimer Disease Polygenic Risk Score to Predict Memory Decline in Black and White Americans Over 14 Years of Follow-up.
    Marden JR; Mayeda ER; Walter S; Vivot A; Tchetgen Tchetgen EJ; Kawachi I; Glymour MM
    Alzheimer Dis Assoc Disord; 2016; 30(3):195-202. PubMed ID: 26756387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease.
    Mattsson N; Eriksson O; Lindberg O; Schöll M; Lampinen B; Nilsson M; Insel PS; Lautner R; Strandberg O; van Westen D; Zetterberg H; Blennow K; Palmqvist S; Stomrud E; Hansson O
    Neurobiol Aging; 2018 Nov; 71():81-90. PubMed ID: 30107289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Caffeine Consumption and Brain Amyloid Positivity in Cognitively Normal Older Adults.
    Zheng YB; Sun J; Shi L; Su SZ; Chen X; Wang QW; Huang YT; Wang YJ; Zhu XM; Que JY; Zeng N; Lin X; Yuan K; Yan W; Deng JH; Shi J; Bao YP; Lu L
    J Alzheimers Dis; 2023; 93(2):483-493. PubMed ID: 37038808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions.
    Ohm TG; Scharnagl H; März W; Bohl J
    Acta Neuropathol; 1999 Sep; 98(3):273-80. PubMed ID: 10483785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.